Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue: Complete Statistical AnalysisIndependent statistical analysis of Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01611259).
- Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells: primary endpoint results, effect estimate with confidence…
- Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RIVALIndependent statistical analysis of A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RJIndependent statistical analysis of RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RLICCIndependent statistical analysis of Effect of Number of Remote Limb Ischemic Conditioning Cycles on Learning Enhancement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RLP-MHIndependent statistical analysis of Reproductive Life Planning for Women With Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03969589).
- RLSIndependent statistical analysis of Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RLS-PractiseIndependent statistical analysis of Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RMCL-CL001Independent statistical analysis of Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RMTMVAIndependent statistical analysis of Effects of Respiratory Muscle Training in Mechanically Ventilated Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02469064).
- RN-Led Palliative and Supportive Care Intervention: Complete Statistical AnalysisIndependent statistical analysis of RN-Led Palliative and Supportive Care Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04570709).
- RN624 In Adult Patients With Chronic Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of RN624 In Adult Patients With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00584870).
- RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROADACEIndependent statistical analysis of Reactions of Older Adults Driving After Cannabis Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04629716).
- ROBOPHYSEIndependent statistical analysis of Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743442).
- Robotic and Conventional Hand Therapy After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Robotic and Conventional Hand Therapy After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03020576).
- Robotic Arm Assisted Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Robotic Arm Assisted Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02058069).
- Robotic Bronchoscopy for Peripheral Pulmonary Lesions: Complete Statistical AnalysisIndependent statistical analysis of Robotic Bronchoscopy for Peripheral Pulmonary Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03727425).
- Robotic Gait Rehabilitation in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Robotic Gait Rehabilitation in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05218187).
- Robotic Hand Orthosis Providing Grasp Assistance for Patients With Brachial Plexus Injuries: Complete Statistical AnalysisIndependent statistical analysis of Robotic Hand Orthosis Providing Grasp Assistance for Patients With Brachial Plexus Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Robotic Pedaling Therapy for Targeted Neural Plasticity: Complete Statistical AnalysisIndependent statistical analysis of Robotic Pedaling Therapy for Targeted Neural Plasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03300258).
- Robotic Single Port Donor Nephrectomy: Complete Statistical AnalysisIndependent statistical analysis of Robotic Single Port Donor Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01925677).
- Robotic Walking Device to Improve Mobility in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Robotic Walking Device to Improve Mobility in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03751371).
- Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Robotics For Rehabilitation Therapy: Functional Versus Individual Joint Training: Complete Statistical AnalysisIndependent statistical analysis of Robotics For Rehabilitation Therapy: Functional Versus Individual Joint Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01050231).
- Robots Paired With tDCS in Stroke Recovery: Complete Statistical AnalysisIndependent statistical analysis of Robots Paired With tDCS in Stroke Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01726673).
- ROBUSTIndependent statistical analysis of Multicenter Prospective Trial of Office-based Carpal Tunnel Release With Ultrasound Guidance (ROBUST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ROCKIndependent statistical analysis of A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma: primary…
- ROCKAIndependent statistical analysis of Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02627924).
- ROCKETIndependent statistical analysis of A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Rocket-1Independent statistical analysis of Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ROCKET-ASTROIndependent statistical analysis of A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rocket-BPSIndependent statistical analysis of Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ROCKIIndependent statistical analysis of Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02616380).
- ROCSIndependent statistical analysis of Risk of Oxygen During Cardiac Surgery Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02361944).
- RODIN-CDIndependent statistical analysis of Trial of High Dose Vitamin D in Patient's With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS): Complete Statistical AnalysisIndependent statistical analysis of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS): primary endpoint results, effect estimate with confidence…
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664624).
- Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02079844).
- ROIDS-DoseIndependent statistical analysis of Randomized Open Investigation Determining Steroid Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04834375).
- ROISIndependent statistical analysis of UK Ibrance Patient Program (IPP) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03921866).
- Role of Apathy in the Effectiveness of Weight Loss Interventions: Complete Statistical AnalysisIndependent statistical analysis of Role of Apathy in the Effectiveness of Weight Loss Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00548652).
- Role of Bone in Knee Osteoarthritis (OA): Complete Statistical AnalysisIndependent statistical analysis of Role of Bone in Knee Osteoarthritis (OA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00850538).
- Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…